Is physical therapy beneficial for osteoarthritis?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 21, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Physical Therapy is Beneficial for Osteoarthritis, Particularly for Patients with Higher Baseline Pain and Disability

Physical therapy (therapeutic exercise) should be recommended as a core first-line treatment for osteoarthritis, especially for patients with higher pain severity and worse functional limitations at baseline, as these individuals derive the most clinically meaningful benefit. 11

Evidence for Effectiveness

International clinical guidelines consistently recommend therapeutic exercise as core management for hip and knee osteoarthritis 23. The most comprehensive 2023 individual participant data meta-analysis of 31 randomized controlled trials (n=4,241) demonstrated that therapeutic exercise reduces pain and improves physical function compared to non-exercise controls 11:

Pain reduction (0-100 scale):

  • Short-term (12 weeks): -6.36 points (95% CI -8.45 to -4.27)
  • Medium-term (6 months): -3.77 points (95% CI -5.97 to -1.57)
  • Long-term (12 months): -3.43 points (95% CI -5.18 to -1.69)

Function improvement (0-100 scale):

  • Short-term: -4.46 points (95% CI -5.95 to -2.98)
  • Medium-term: -2.71 points (95% CI -4.63 to -0.78)
  • Long-term: -3.39 points (95% CI -4.97 to -1.81)

Critical Nuance: Who Benefits Most

The key finding is that baseline pain and functional status moderate treatment response 11. Patients with higher pain severity and poorer physical function at baseline benefit substantially more than those with milder symptoms. This differential response explains why average effect sizes appear modest—they mask clinically important benefits in the subgroup that needs it most 1.

Factors that do NOT predict response include: age, BMI, physical activity level, mental wellbeing, comorbidity, muscle strength, education level, pain duration, or radiographic severity 1. This means you cannot exclude patients based on these characteristics.

Practical Implementation

Minimum effective dose: At least 12 supervised sessions, delivered twice weekly initially, are required to obtain sufficient clinical benefit 4. This is not optional—unsupervised or minimal-contact programs are less effective.

Exercise modalities: The specific type of exercise (strengthening, aerobic, aquatic, neuromuscular) matters less than consistent delivery 15. Technology-supported delivery (telehealth, apps with automated messaging) shows small but significant benefits and can improve accessibility 2.

Comparative effectiveness: Physical therapy demonstrates superior long-term outcomes compared to glucocorticoid injections. At 1 year, patients receiving physical therapy had 18.8 points better WOMAC scores than those receiving injections 6. Exercise provides pain relief comparable to pharmacological medications without serious adverse effects 4.

Common Pitfalls to Avoid

  1. Don't dismiss exercise for patients with mild symptoms—while they benefit less, exercise remains safe and provides general health benefits 1

  2. Don't prescribe exercise alone without education—structured patient education about osteoarthritis and self-management is essential for maintaining long-term adherence and sustained effects 24

  3. Don't expect dramatic improvements in everyone—the overall effects are small to moderate, and effects diminish over time if not maintained 11. Set realistic expectations, particularly for patients with lower baseline pain.

  4. Don't use exercise as a substitute for surgery in appropriate candidates—exercise is less effective than knee osteotomy and joint replacement in selected populations requiring these interventions 7

Honest Assessment of Limitations

Recent evidence questions the magnitude of benefit, particularly in the medium and long term 11. A 2026 overview found effects in larger, longer-term trials were smaller than earlier studies suggested, with very low certainty evidence for knee osteoarthritis 7. However, given the safety profile, general health benefits, and clear benefit in high-symptom patients, physical therapy remains justified as first-line treatment 12.

The 2024 EULAR recommendations continue to endorse exercise as core management, emphasizing that delivery methods should align with patient preferences and local service availability 2.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.